8[1]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. 9th Information standard M100-S9. Pennsylvania: NCCLS, 1999. 1-103.
9[4]Quale JM, Landman D, Bradford PA, et al. Molecular epidemiology of a citywide outbreak of extended spectrum-beta-lactamase-producing Klebsiella pneumoniae infection[J]. Clin Infect Dis, 2002, 35(7): 834-841.
10Elisabeth Meyer,Frank Schwab,Daniel Jonas,et al.Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI):1.Antimicrobial use in German intensive care units[J].Intensive Care Medicine,2004,30(6):1 089.
5National Committee for Clinical Laboratory Standards.Perfermance standards for antimierobial susceptibility testing[M].Eleventh informational supplement.M 100-S11.Pennsylvania:NCCLS,2001.
6Pfaller MA,Jones RN.Ant imicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Merop enem Yearly Susceptibility Test Information Collection(MYSTIC)Programme.Europe 1997-2000[J].Int J Antimicrob Agents,2002,19(5):383-388.
7Yuan M,Aucken H,Hall LM,et al.D.M.Epidemioiogical typing of klebsiellae with extended-spectrumbeta-lactamases from European intensive care units[J].J Antimicrob.Chemother,1998,41(5):527-539.
8Yuan M, Aucken H, Hall LM, et al.Epidemioiogical typing of kleb- siellae with extended-speetrumbeta-lactamases from European inten- sive egre units[J].J Antimi- crob.Chemother, 1998,41(5) :527.
9Clinical and Laboratory Standards Institute. Performance standardsfor antimicrobial susceptibility testing; Twentieth informational supplement. 2010.
10Petrella S, Ziental-Gelus N, Mayer C, et al. Genetic and structural insighis into the dissemination potential of the extremely broad-spectrum class A beat-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother, 2008.52(10) _.3725-3736.
